www.wired.com Open in urlscan Pro
151.101.2.194  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to main content

Open Navigation Menu
Menu
Story Saved

To revist this article, visit My Profile, then View saved stories.

Close Alert
Close

Australia Moves Ahead Cautiously With '3-Parent IVF'
 * Backchannel
 * Business
 * Culture
 * Gear
 * Ideas
 * Science
 * Security

Story Saved

To revist this article, visit My Profile, then View saved stories.

Close Alert
Close
Sign In


Search
Search
 * Backchannel
 * Business
 * Culture
 * Gear
 * Ideas
 * Science
 * Security

 * Podcasts
 * Video
 * Artificial Intelligence
 * Climate
 * Games
 * Newsletters
 * Magazine
 * Events
 * Wired Insider
 * Coupons




Emily Mullin

Science
Apr 29, 2022 8:00 AM


AUSTRALIA MOVES AHEAD CAUTIOUSLY WITH '3-PARENT IVF'

The nation follows the UK in permitting mitochondrial donation, which aims to
prevent the transmission of rare but often fatal conditions.
 * Facebook
 * Twitter
 * Email
 * Save Story

   To revist this article, visit My Profile, then View saved stories.

Photograph: Getty Images

 * Facebook
 * Twitter
 * Email
 * Save Story

   To revist this article, visit My Profile, then View saved stories.



Australia has become the second country after the United Kingdom to legalize a
fertility procedure that mixes genetic material from three people. The technique
is meant to prevent couples from having children with certain debilitating
disorders caused by faulty mitochondria, the energy-generating structures in our
cells. But it’s controversial because it involves a genetic change that can be
passed to future generations, so its rollout in Australia will be extremely
cautious.

On March 30, the Australian Senate passed the Mitochondrial Donation Law Reform
Bill, also known as Maeve’s Law, named after a 6-year-old Australian girl with a
mitochondrial disorder called Leigh syndrome. The disease causes a loss of
mental abilities and motor skills over time, and those born with it typically do
not survive beyond childhood.

Mitochondria have their own DNA, which is passed to children from their mother’s
egg. If a mother carries mutations in her mitochondrial DNA for disorders like
Leigh syndrome, she could have a child with one of these diseases. These
disorders are rare but often fatal, and treatments are extremely limited.



Mitochondrial donation, also known as mitochondrial replacement therapy, was
developed as a way to let the mother pass along almost all of her genetic
material—but not the mitochondrial DNA. The procedure takes advantage of the
fact that the vast majority of our DNA resides in the nucleus of our cells,
while the mitochondria float around in the gelatinous fluid outside the nucleus.

It works like this: The nucleus from a donor egg is replaced with the nucleus
from the mother’s egg, leaving the donor’s healthy mitochondria intact while
keeping nearly all of the mother’s DNA. The combined egg is then fertilized with
sperm through in-vitro fertilization and transferred to the uterus of the mother
so she can carry the pregnancy. The procedure is often referred to as
“three-parent IVF,” because the baby has DNA from three biological parents,
though the contribution from the egg donor is tiny.



Patient advocates in Australia and elsewhere see the new law as a win for women
who are at risk of passing on these diseases. “This law provides mitochondrial
disease patients in Australia with a pathway to having a genetically related
child while minimizing the risk of mitochondrial disease transmission from
mother to child, which is a significant unmet medical need,” says Philip Yeske,
science and alliance officer at the United Mitochondrial Disease Foundation, a
nonprofit based in Pennsylvania.



Yet the procedure raises thorny ethical questions. It is banned in the United
States because of a legal provision prohibiting the creation of human embryos
that involve a heritable genetic change. While some see it as an extension of
IVF, others have argued that it could open the door to the gene editing of
embryos, including for human enhancement.



Both the Australian and UK laws passed after years of public debate and input.
One point of contention during the legislative process in Australia was whether
to allow prospective parents to choose only male embryos for mitochondrial
donation. Since female embryos transmit mitochondria—and thus mitochondrial
diseases—some have argued that it should be possible to select only male embryos
to limit the risk of transmitting these diseases to future generations. However,
Australia doesn’t allow sex selection for IVF, so legislators removed a
provision in the bill that would have permitted that distinction.

Featured Video



How Dogs Coevolved with Humans



Most Popular
 * Security
   
   North Koreans Are Jailbreaking Phones to Access Forbidden Media
   
   Andy Greenberg

 * Security
   
   Russia Is Being Hacked at an Unprecedented Scale
   
   Matt Burgess

 * Gear
   
   28 Mother's Day Gift Ideas for the Mom You've Been Missing
   
   Brenda Stolyar and Adrienne So

 * Security
   
   Hollywood’s Fight Against VPNs Turns Ugly
   
   Ax Sharma

 * 





Australia’s cautious approach is similar to that of the UK, where Parliament
voted to legalize mitochondrial donation in 2015. There, only one clinic,
Newcastle Fertility Centre, is licensed to perform the procedure. It must appeal
to the UK's fertility agency, the Human Fertilisation and Embryology Authority,
to approve patients on a case-by-case basis.

Under the new Australian law, mitochondrial donation will initially be offered
at just one fertility clinic as part of a clinical trial. The trial likely won’t
begin for another year or two, and once underway it is expected to last 10 to 12
years. Families interested in joining the trial will need to attend counseling
to discuss potential risks involved in mitochondrial donation, and participants
will ultimately need to be approved by a board of experts.

The law requires researchers to track participants' pregnancies and birth
outcomes, including any miscarriages, premature births, birth defects, or
instances of mitochondrial disease among babies born from these pregnancies.
Investigators will also monitor the ongoing health and development of children
born as a result of the trial.

In contrast to the law in the UK, Australian children born from this procedure
will be able to access identifying information about the egg donor in the same
manner as children born as a result of egg donation.

The number of participants for the trial hasn’t been determined yet, but
according to an April 10 funding announcement by the Australian government, the
trial must “provide a pathway for impacted families to access the technology.”
While about one in 5,000 babies are born in Australia with a severely disabling
form of mitochondrial disease, not all women with mitochondrial disease will
need access to this technology, says Megan Munsie, a stem cell scientist and
professor of emerging technology at the University of Melbourne.

“The reform rightly limits the use of mitochondrial donation to circumstances
where this is the only option available to them to reduce the risk of a woman’s
child inheriting mitochondrial DNA disease that is likely to result in serious
illness,” she says. “Depending on how the disease affects their mitochondria,
other assisted reproductive technologies, such as preimplantation genetic
testing, will be sufficient.” This type of testing allows prospective parents
going through IVF to select only healthy embryos to implant.

Even after Australia’s trial period, it’s not a given that the technology will
be made more widely available to women who carry mitochondrial DNA mutations.
“It is not yet certain that the technology will be implemented clinically,” says
Catherine Mills, director of the Monash Bioethics Centre in Australia. That will
depend on the outcome of the clinical trial, which will weigh safety and
efficacy.



There are two major safety concerns with the procedure, says David Thorburn, a
mitochondrial disease researcher at the Murdoch Children's Research Institute in
Melbourne. One is that a small amount of “carryover” mitochondrial DNA from the
mother could end up in the baby. “There may be potential for this to increase to
a higher amount during development, such that it could result in mitochondrial
disease,” he says.

Most Popular
 * Security
   
   North Koreans Are Jailbreaking Phones to Access Forbidden Media
   
   Andy Greenberg

 * Security
   
   Russia Is Being Hacked at an Unprecedented Scale
   
   Matt Burgess

 * Gear
   
   28 Mother's Day Gift Ideas for the Mom You've Been Missing
   
   Brenda Stolyar and Adrienne So

 * Security
   
   Hollywood’s Fight Against VPNs Turns Ugly
   
   Ax Sharma

 * 





The other is the possibility of incompatibility between the mother’s nuclear DNA
and the egg donor’s mitochondrial DNA. However, scientists in both Australia and
the UK concluded that the risk of either causing disease was low.

Clinics in Greece and Ukraine are using mitochondrial donation as a way to treat
infertility, despite the lack of evidence that it leads to higher birth rates
compared with traditional IVF. The clinics claim it has led to several healthy
births among these mothers. But only one baby conceived through this method in
order to circumvent mitochondrial disease is known to have been born
disease-free. The baby, a boy, was born in 2016 to a mother who carried genes
for Leigh syndrome. The disease killed her first two children. She underwent the
procedure in Mexico, where there are no laws on the books that prohibit it. In a
2017 peer-reviewed paper, her fertility doctor and his team revealed that a
small percentage of mutated mitochondrial DNA from the mother unintentionally
ended up in the healthy donor egg. But it’s unknown how it has affected the
child’s long-term health because his parents refused additional testing and
monitoring.

So far, Newcastle Fertility Centre has not released any data on how many
mitochondrial donation procedures it has performed or how many births have
resulted from it. The HFEA and Newcastle Fertility Centre did not respond to
requests from WIRED for this information.

“There was a lot of excitement when the UK first legalized this several years
ago, so it's surprising that there haven't been reports of failures or successes
one way or the other,” says I. Glenn Cohen, director of Harvard Law School's
Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, who has
been following the international landscape of mitochondrial donation closely.

The Australian trial “will provide much-needed clarity on the effectiveness and
safety of mitochondrial techniques,” Munsie says.

In the United States, Democratic members of Congress attempted to revisit the
ban on genetically altering embryos for IVF in 2019, but Republicans restored
the provision. With both Australia and the UK allowing mitochondrial donation to
proceed cautiously, there could be a renewed US efforts to legalize the
procedure. “I do think there’s a good chance that there will be more pressure in
the United States to revisit this question,” says Cohen.

--------------------------------------------------------------------------------

More Great WIRED Stories
 * 📩 The latest on tech, science, and more: Get our newsletters!
 * Sober influencers and the end of alcohol
 * For mRNA, Covid vaccines are just the beginning
 * The future of the web is AI-generated marketing copy
 * Keep your home connected with the best wi-fi routers
 * How to limit who can contact you on Instagram
 * 👁️ Explore AI like never before with our new database
 * 🏃🏽‍♀️ Want the best tools to get healthy? Check out our Gear team’s picks
   for the best fitness trackers, running gear (including shoes and socks), and
   best headphones





Emily Mullin is a Pittsburgh-based health and science journalist who's
interested in biotechnology, genetics, and neuroscience. She holds an MA in
Science Writing from Johns Hopkins University, where she now teaches.
Contributor

TopicshealthReproductionbabiesDNAgeneticsGenomicsdiseasesbioethicsfertility



WIRED is where tomorrow is realized. It is the essential source of information
and ideas that make sense of a world in constant transformation. The WIRED
conversation illuminates how technology is changing every aspect of our
lives—from culture to business, science to design. The breakthroughs and
innovations that we uncover lead to new ways of thinking, new connections, and
new industries.
 * Facebook
 * Twitter
 * Pinterest
 * YouTube
 * Instagram
 * Tiktok

More From WIRED

 * Subscribe
 * Newsletters
 * FAQ
 * Wired Staff
 * Press Center
 * Coupons
 * Editorial Standards

Contact

 * Advertise
 * Contact Us
 * Customer Care
 * Jobs

 * RSS
 * Site Map
 * Accessibility Help
 * Condé Nast Store
 * Condé Nast Spotlight
 * Manage Preferences

© 2022 Condé Nast. All rights reserved. Use of this site constitutes acceptance
of our User Agreement and Privacy Policy and Cookie Statement and Your
California Privacy Rights. Wired may earn a portion of sales from products that
are purchased through our site as part of our Affiliate Partnerships with
retailers. The material on this site may not be reproduced, distributed,
transmitted, cached or otherwise used, except with the prior written permission
of Condé Nast. Ad Choices










WE CARE ABOUT YOUR PRIVACY

We and our partners store and/or access information on a device, such as unique
IDs in cookies to process personal data. You may accept or manage your choices
by clicking below or at any time in the privacy policy page. These choices will
be signaled to our partners and will not affect browsing data.


WE AND OUR PARTNERS PROCESS DATA TO PROVIDE:

Use precise geolocation data. Actively scan device characteristics for
identification. Store and/or access information on a device. Personalised ads
and content, ad and content measurement, audience insights and product
development. List of Partners (vendors)

I Accept
Show Purposes